Oracle–s Industry-Leading Clinical R&D Cloud Solutions Help Emerging Biopharmaceutical Firms Optimize Clinical Development Productivity and Facilitate Compliance, While Delivering an Affordable Pricing Model and Rapid Deployment
EDC Platform Offering Direct Data Entry by Patients, Foreign Language Support, and Automated E2B Safety Reporting
FORT LAUDERDALE, FL — (Marketwired) — 03/11/15 — OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that after a rigorous evaluation process of various commercially available EDC technologies, Veloxis selected TrialMaster EDC to run its Phase IV clinical studies.TrialMaster–s risk-based monitoring capability was a significant factor in the selection decision. The ability to collect and utilize many types of key
FORT LAUDERDALE, FL — (Marketwired) — 03/03/15 — OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced the signing of a multi-year agreement with ICON for OmniComm Systems– market leading TrialOne technology for Phase I clinic automation. ICON is one of the world–s largest contract research organizations (CROs) with around 10,600 employees in 38 countries. ICON provides drug development solutions and services on a
FORT LAUDERDALE, FL — (Marketwired) — 02/24/15 — OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces that the European Group for Research in Schizophrenia (EGRIS) has selected TrialMaster electronic data capture (EDC) technology with risk-based and centralized monitoring for its European Long-acting Antipsychotics in Schizophrenia Trial (EULAST). The EULAST trial will span 16 countries, involve 45 investigator sites, en
FORT LAUDERDALE, FL — (Marketwired) — 02/09/15 — OmniComm Systems, Inc. (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, announces the appointment of Mr. Feng Cheng as general manager of OmniComm, China. Mr. Cheng will lead OmniComm–s long-term regional strategy, identifying and developing business expansion and growth initiatives.Recent market research has estimated that the Asia-Pacific region is poised to grow at CAGR of 19.5% in the next five y
TrialMaster(R) EDC Suite and IRTMaster(TM) Integrated for Faster Study Start-Up and Site Optimization
World–s Largest CROs and Pharmaceutical Companies Comprise 33% of Total Contract Value
Industry Leaders Convene to Demonstrate the Transformative Effect of OmniComm Technology
FORT LAUDERDALE, FL — (Marketwired) — 11/26/14 — OmniComm Systems, Inc., (OmniComm) (OTCQB: OMCM), a global leading provider of clinical data management technology, today announced that Q3 2014 total contract value was up by over 260% from the same period in 2013. Year-over-year total contract value grew over 135%. New clients accounted for over 73% of all new contracts through Q3 2014 and 20% of all contracts had a term life in excess of 30 months. The record contract growth is attributed t